Evidence map›Paper›PMID 29275306›Full record

ArticleIn vivo (Athens, Greece)

Silver Nanoparticles Alter Cell Adhesion and Proliferation of Sheep Primary Mesothelial Cells.

Zoi V Arsenopoulou, Ioannis A Taitzoglou, Paschalis-Adam Molyvdas, Konstantinos I Gourgoulianis, Chrissi Hatzoglou, Sotirios G Zarogiannis

Abstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Fluoroplast Doped by AgInternational journal of molecular sciences · 2023
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zoi V ArsenopoulouDepartment of Physiology, Faculty of Medicine, University of Thessaly, BIOPOLIS, Larissa, Greece.
Ioannis A TaitzoglouLaboratory of Physiology, Faculty of Veterinary Medicine, Aristotle University, Thessaloniki, Greece.
Paschalis-Adam MolyvdasDepartment of Physiology, Faculty of Medicine, University of Thessaly, BIOPOLIS, Larissa, Greece.
Konstantinos I GourgoulianisDepartment of Respiratory Medicine, Faculty of Medicine, University of Thessaly, BIOPOLIS, Larissa, Greece.
Chrissi HatzoglouDepartment of Physiology, Faculty of Medicine, University of Thessaly, BIOPOLIS, Larissa, Greece.
Sotirios G ZarogiannisDepartment of Physiology, Faculty of Medicine, University of Thessaly, BIOPOLIS, Larissa, Greece szarog@med.uth.gr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman exposure to engineered nanoparticles has been linked to pleural effusion, inflammation and fibrosis. Silver nanoparticles (AgNPs) are widely used in medical and domestic products, increasing the risk of occupational and domestic exposure. We assessed the influence of AgNPs on adhesion and proliferation of sheep primary pleural mesothelial cells. MATERIALS AND

methodsCells were used for cell adhesion (90 min) and proliferation experiments (3 days) while exposed to 20 nm and 60 nm AgNPs (0.2 μg/ml and 2 μg/ml) using colorimetric assays.

resultsExposure to 0.2 μg/ml of 20 nm and 60 nm AgNPs significantly increased cell adhesion, while at 2 μg/ml this effect was not elicited. Cell proliferation was significantly increased by both 20 nm and 60 nm AgNPs at 0.2 μg/ml, while at 2 μg/ml this effect was only elicited by the 60 nm AgNPs.

conclusionAgNPs alter the adhesive and proliferative properties of primary pleural mesothelial cells.

Indexed as

AnimalsCell AdhesionCell ProliferationCells, CulturedDose-Response Relationship, DrugEpithelial CellsMetal NanoparticlesParticle SizePleuraSheepSilverSilverCell adhesioncell proliferationmesothelialpleurasilver nanoparticles

Identifiers

PMID29275306
PMCPMC5892624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.